Inflammatory exposure and historical changes in human life-spans

Science
Caleb E Finch, Eileen M Crimmins

Abstract

Most explanations of the increase in life expectancy at older ages over history emphasize the importance of medical and public health factors of a particular historical period. We propose that the reduction in lifetime exposure to infectious diseases and other sources of inflammation--a cohort mechanism--has also made an important contribution to the historical decline in old-age mortality. Analysis of birth cohorts across the life-span since 1751 in Sweden reveals strong associations between early-age mortality and subsequent mortality in the same cohorts. We propose that a "cohort morbidity phenotype" represents inflammatory processes that persist from early age into adult life.

References

Jun 7, 1990·The New England Journal of Medicine·P A SytkowskiR B D'Agostino
Mar 1, 1982·Journal of Epidemiology and Community Health·C Buck, H Simpson
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·S O ShaheenS T Holgate
Jun 1, 1997·American Journal of Epidemiology·V KannistoJ W Vaupel
Aug 24, 2000·The American Journal of Cardiology·J ZhuS E Epstein
Sep 29, 2000·Science·J R WilmothS Horiuchi
Oct 12, 2000·Clinical Microbiology Reviews·X LiI Olsen
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·G Doblhammer, J W Vaupel
Apr 3, 2001·Social Science & Medicine·D L BlackwellE M Crimmins
May 11, 2002·Science·Jim Oeppen, James W Vaupel
Jul 30, 2002·QJM : Monthly Journal of the Association of Physicians·R F HarveyJ Donovan
Sep 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wulf Palinski, Claudio Napoli
Oct 9, 2002·Trends in Endocrinology and Metabolism : TEM·David J P Barker
Feb 25, 2003·Lancet·Anthony H Vagnucci, William W Li
Apr 26, 2003·International Journal of Epidemiology·Tommy Bengtsson, Martin Lindström
Aug 28, 2003·Lancet Neurology·John C S Breitner
Jan 1, 1956·Advances in Biological and Medical Physics·H B JONES

❮ Previous
Next ❯

Citations

Apr 22, 2010·JAMA : the Journal of the American Medical Association·Emre OzaltinS V Subramanian
Jun 16, 2010·Biogerontology·Giuseppina CandoreGiuseppina Colonna-Romano
Oct 8, 2008·European Journal of Epidemiology·Rune JacobsenKaare Christensen
Dec 23, 2011·Age·James G HerndonMargaret L Walker
Jun 28, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Remi-Martin LabergePierre-Yves Desprez
Jun 1, 2010·Journal of Developmental Origins of Health and Disease·R MezaR C Brunham
Apr 30, 2013·Journal of Developmental Origins of Health and Disease·H Beltrán-SánchezaC E Finch
Jan 15, 2013·Journal of Developmental Origins of Health and Disease·M McEniry
Apr 1, 2013·Journal of Developmental Origins of Health and Disease·H A Hanson, K R Smith
Aug 30, 2008·Nature·Jan Vijg, Judith Campisi
Mar 1, 2006·Nature Clinical Practice. Cardiovascular Medicine·Anatol Kontush, M John Chapman
Jan 7, 2006·Nature Reviews. Cancer·Karin E de VisserLisa M Coussens
May 19, 2006·Nature Reviews. Genetics·Kaare ChristensenJames W Vaupel
Apr 5, 2005·Nature Reviews. Microbiology·Alistair J Lax
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Robert E Ricklefs
Nov 7, 2009·The Journal of Biological Chemistry·Alexey A TomilovGino A Cortopassi
Sep 1, 2010·Death Studies·Ernest L Abel, Michael L Kruger
Feb 26, 2010·Biodemography and Social Biology·Thomas W McDade, Mark D Hayward
Aug 19, 2011·Biodemography and Social Biology·Sarinnapha VasunilashornHooman Allayee
May 16, 2012·Biodemography and Social Biology·Leonid A Gavrilov, Natalia S Gavrilova
Apr 13, 2006·Rejuvenation Research·Giuseppina CandoreCalogero Caruso
Dec 6, 2008·American Journal of Epidemiology·Abraham AvivGerald S Berenson
Jan 21, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Naoko OkayamaYuji Hinoda
Jan 21, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Athanase BenetosAbraham Aviv
Aug 17, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Abraham Aviv
May 25, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Naoko OkayamaYuji Hinoda
Mar 4, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Michael GurvenEileen M Crimmins
Oct 9, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Abraham Aviv
Jan 20, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Serena DatoLene Christiansen
Jul 27, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Paul G SurteesAlison M Dunning
Apr 3, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Holly M Brown-Borg, Andrzej Bartke
Dec 17, 2009·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Yang Yang, Linda C Lee
Apr 21, 2009·The Gerontologist·Kenneth F Ferraro, Tetyana Pylypiv Shippee
Dec 20, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Yves GuigozEduardo J Schiffrin
Dec 21, 2012·Journal of the Royal Society, Interface·Mateusz M PlucińskiMatthew H Bonds
Jul 19, 2006·Proceedings. Biological Sciences·Robert E Ricklefs
Dec 17, 2009·Proceedings. Biological Sciences·Thomas W McDadeChristopher W Kuzawa
Oct 22, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Gabriele Sorci, Bruno Faivre
Mar 6, 2008·Annual Review of Biochemistry·Michael P Murphy, Linda Partridge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.